Therapeutic Peptides Expanded 2 intermediate
Aducanumab: Oligopeptide Research Reference
Aducanumab, a bioactive peptide compound with documented applications in biomedical research, pharmacological studies, and therapeutic development
By Encyclopeptide Editorial | 1 min read
therapeutic-peptides-expanded-2 peptide oligopeptide
Overview
Aducanumab is a bioactive peptide with well-characterized properties and therapeutic applications.
Structure
| Property | Value |
|---|---|
| Name | Aducanumab |
| Sequence | Fully human IgG1 monoclonal antibody targeting aggregated amyloid-beta (Aβ) fibrils and soluble oligomers |
| Length | ~1332 amino acids (full-length antibody) |
| Molecular Weight | ~148 kDa |
| Category | Neurology / Anti-Amyloid Antibody |
Mechanism of Action
Selectively binds aggregated Aβ plaques (fibrillar and soluble oligomers), promoting microglial-mediated clearance via Fc-receptor phagocytosis
References
- Wikipept Peptide Database
- Primary literature (see individual entries)
Test Your Knowledge
Reinforce what you learned about Aducanumab: Oligopeptide Research Reference with interactive quizzes on Wikipept.
Take a Quiz on Wikipept